1. Home
  2. AIM vs CJET Comparison

AIM vs CJET Comparison

Compare AIM & CJET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIM
  • CJET
  • Stock Information
  • Founded
  • AIM 1966
  • CJET 2009
  • Country
  • AIM United States
  • CJET China
  • Employees
  • AIM N/A
  • CJET N/A
  • Industry
  • AIM Biotechnology: Biological Products (No Diagnostic Substances)
  • CJET Auto Manufacturing
  • Sector
  • AIM Health Care
  • CJET Consumer Discretionary
  • Exchange
  • AIM Nasdaq
  • CJET Nasdaq
  • Market Cap
  • AIM 15.9M
  • CJET 14.3M
  • IPO Year
  • AIM N/A
  • CJET N/A
  • Fundamental
  • Price
  • AIM $0.21
  • CJET $1.76
  • Analyst Decision
  • AIM Strong Buy
  • CJET
  • Analyst Count
  • AIM 2
  • CJET 0
  • Target Price
  • AIM $2.75
  • CJET N/A
  • AVG Volume (30 Days)
  • AIM 672.1K
  • CJET 69.5K
  • Earning Date
  • AIM 11-15-2024
  • CJET 01-28-2025
  • Dividend Yield
  • AIM N/A
  • CJET N/A
  • EPS Growth
  • AIM N/A
  • CJET N/A
  • EPS
  • AIM N/A
  • CJET N/A
  • Revenue
  • AIM $190,000.00
  • CJET $10,275,000.00
  • Revenue This Year
  • AIM N/A
  • CJET N/A
  • Revenue Next Year
  • AIM $1,693.10
  • CJET N/A
  • P/E Ratio
  • AIM N/A
  • CJET N/A
  • Revenue Growth
  • AIM N/A
  • CJET 31.31
  • 52 Week Low
  • AIM $0.16
  • CJET $1.65
  • 52 Week High
  • AIM $0.62
  • CJET $23.94
  • Technical
  • Relative Strength Index (RSI)
  • AIM 50.86
  • CJET 37.95
  • Support Level
  • AIM $0.19
  • CJET $1.93
  • Resistance Level
  • AIM $0.23
  • CJET $2.08
  • Average True Range (ATR)
  • AIM 0.02
  • CJET 0.17
  • MACD
  • AIM -0.00
  • CJET -0.06
  • Stochastic Oscillator
  • AIM 48.29
  • CJET 10.71

About AIM AIM ImmunoTech Inc.

AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders and viral and cancer diseases. AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular RNA molecules for cancer and viral diseases, and the drug Alferon N Injection for a category of STD infection. Clinical trials of Ampligen include studies of cancer patients with renal cell carcinoma, malignant melanoma, colorectal cancer, advanced recurrent ovarian cancer, and triple-negative metastatic breast cancer. It is also advancing Ampligen as a potential treatment for COVID-19. FDA has authorized the first human trial assessing the safety and effectiveness of Ampligen in combination with interferon alfa-2b, in cancer patients with COVID-19.

About CJET Chijet Motor Company Inc.

Chijet Motor Co Inc is engaged in the research and development, production and sales of new energy vehicles. New energy vehicles refer to plug-in electric vehicles including battery electric vehicles, plug-in hybrid (PHEV) electric vehicles, and fuel cell electric vehicles. Its passenger vehicles include small cars, sedans, and sports utility vehicles, or SUVs, and commercial vehicles include light trucks and vans.

Share on Social Networks: